English
  1. Home
  2. Stocks
  3. Ipcalab Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Ipca Laboratories

    Large Cap
    ₹1,434.65
    -19.7 (-1.35%)
    • Advice
    • Hold
    21 September, 2024 04:30 BSE: 524494 NSE: IPCALABISIN: INE571A01038
    Split

    Start SIP in Ipca Laboratories

    Start SIP

    Ipca Laboratories Performance

    Day Range

    • Low 1,428
    • High 1,459
    ₹ 1,434

    52 Week Range

    • Low 878
    • High 1,480
    ₹ 1,434
    • Open Price1,445
    • Previous Close1,454
    • Volume446166

    Ipca Laboratories Share Price

    • Over 1 Month +6.02%
    • Over 3 Month +26.58%
    • Over 6 Month +25.39%
    • Over 1 Year +54.67%

    Ipca Laboratories Key Statistics

    P/E Ratio 63.1
    PEG Ratio 3.6
    Market Cap Cr
    Price to Book Ratio 4.7
    EPS 23.6
    Dividend 0.3
    Relative Strength Index 56.5
    Money Flow Index 72.46
    MACD Signal 32.2
    Average True Range 33.88

    Ipca Laboratories F&O

    Ipca Laboratories Futures Ipca Laboratories Option Chain
    Ipca Laboratories Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,5661,5111,5071,6631,4891,402
    Operating Expenses Qtr Cr 1,2131,2181,2331,3541,1911,226
    Operating Profit Qtr Cr 353292273309298176
    Depreciation Qtr Cr 616263616059
    Interest Qtr Cr 192427393118
    Tax Qtr Cr 846363838347
    Net Profit Qtr Cr 2046513716216785
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 6,2785,926
    Operating Expenses Annual Cr 4,9554,903
    Operating Profit Annual in Cr 1,211912
    Depreciation Cr 246229
    Interest Annual Cr 12144
    Tax Annual Cr 292245
    Net Profit Annual Cr 530506
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 831762
    Cash from Investing Activity Annual Cr -1,355-710
    Cash from Financing Annual Activity Cr -465506
    Net Cash Flow Annual Cr -990559
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 6,3495,877
    Fixed Assets Annual Cr 2,6992,602
    Total Non Current Assets Annual Cr 5,1493,572
    Total Current Assets Annual Cr 3,5104,875
    Total Assets Annual Cr 8,6598,447
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 250232
    ROE Annual % 89
    ROCE Annual % 1512
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2118
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 2,0932,0332,0532,0341,5881,512
    Operating Expenses Qtr Cr 1,7001,7111,7221,7131,2801,331
    Operating Profit Qtr Cr 393322331321308181
    Depreciation Qtr Cr 9998100906970
    Interest Qtr Cr 242933443118
    Tax Qtr Cr 917466888648
    Net Profit Qtr Cr 1926018014516377
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 7,8306,370
    Operating Expenses Annual Cr 6,3845,318
    Operating Profit Annual in Cr 1,321927
    Depreciation Cr 357262
    Interest Annual Cr 13846
    Tax Annual Cr 313253
    Net Profit Annual Cr 547471
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 945806
    Cash from Investing Activity Annual Cr -1,292-725
    Cash from Financing Annual Activity Cr -553507
    Net Cash Flow Annual Cr -900588
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 6,3325,842
    Fixed Assets Annual Cr 4,8062,854
    Total Non Current Assets Annual Cr 5,5623,437
    Total Current Assets Annual Cr 5,5395,189
    Total Assets Annual Cr 11,1018,626
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 305233
    ROE Annual % 98
    ROCE Annual % 1212
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1917
    Invest in Ipca Laboratories

    Ipca Laboratories Technicals

    EMA & SMA

    Current Price
    ₹1,434.65
    -19.7 (-1.35%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹1,423.32
    • 50 Day
    • ₹1,364.90
    • 100 Day
    • ₹1,307.71
    • 200 Day
    • ₹1,226.08
    • 20 Day
    • ₹1,423.04
    • 50 Day
    • ₹1,351.54
    • 100 Day
    • ₹1,286.78
    • 200 Day
    • ₹1,232.59

    Ipca Laboratories Resistance and Support

    PIVOT
    ₹1,440.45
    Resistance
    First Resistance 1,453.20
    Second Resistance 1,471.75
    Third Resistance 1,484.50
    RSI 56.50
    MFI 72.46
    MACD Single Line 32.20
    MACD 28.89
    Support
    First Support 1,421.90
    Second Support 1,409.15
    Third Supoort 1,390.60

    Ipca Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 452,414 29,035,931 64.18
    Week 313,518 16,039,591 51.16
    1 Month 381,679 17,236,644 45.16
    6 Month 568,728 26,400,357 46.42

    Ipca Laboratories Result Highlights

    Ipca Laboratories Synopsis

    NSE-Medical-Generic Drugs

    Ipca Laboratorie is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 6166.46 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2024. Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837.
    Market Cap 36,398
    Sales 6,246
    Shares in Float 13.70
    No of funds 255
    Yield 0.28
    Book Value 5.73
    U/D Vol ratio 1.8
    LTDebt / Equity 9
    Alpha 0.16
    Beta 0.45

    Ipca Laboratories Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 46.3%46.3%46.29%46.29%
    Mutual Funds 28.52%28.83%29.25%30.23%
    Insurance Companies 4.63%4.67%4.54%4.12%
    Foreign Portfolio Investors 10.85%10.51%10.27%9.86%
    Financial Institutions/ Banks 0.01%0.01%
    Individual Investors 7.27%7.13%7.12%7.14%
    Others 2.42%2.55%2.53%2.36%

    Ipca Laboratories Management

    Name Designation
    Mr. Premchand Godha Executive Chairman
    Mr. Ajit Kumar Jain Managing Director
    Mr. Pranay Godha Managing Director
    Mr. Prashant Godha Executive Director
    Dr.(Mrs.) Manisha Premnath Independent Director
    Mr. Kamal Kishore Seth Independent Director
    Dr. Narendra Mairpady Independent Director
    Dr.(Ms.) Swati Patankar Independent Director
    Mr. Vivek Shiralkar Independent Director

    Ipca Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Ipca Laboratories Corporate Action

    Date Purpose Remarks
    2024-08-13 Quarterly Results
    2024-05-29 Audited Results & Final Dividend
    2024-02-14 Quarterly Results
    2023-11-10 Quarterly Results & Interim Dividend
    2023-08-10 Quarterly Results
    Date Purpose Remarks
    2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
    2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
    2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
    Date Purpose Remarks
    2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

    Ipca Laboratories MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 95,391
    Parag Parikh Flexi Cap Regular Growth 78,490
    HDFC Mid-Cap Opportunities Fund Growth 75,296
    ICICI Prudential Balanced Advantage Fund Growth 61,103
    Kotak Equity Arbitrage Fund Growth 53,423

    Ipca Laboratories FAQs

    What is Share Price of Ipca Laboratories ?

    Ipca Laboratories share price is ₹1,434 As on 21 September, 2024 | 04:16

    What is the Market Cap of Ipca Laboratories ?

    The Market Cap of Ipca Laboratories is ₹36397.7 Cr As on 21 September, 2024 | 04:16

    What is the P/E ratio of Ipca Laboratories ?

    The P/E ratio of Ipca Laboratories is 63.1 As on 21 September, 2024 | 04:16

    What is the PB ratio of Ipca Laboratories ?

    The PB ratio of Ipca Laboratories is 4.7 As on 21 September, 2024 | 04:16

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.